Niddafin (Terbinafine Hydrochloride)

Terbinafine, the active ingredient in Niddafin, is a allylamine antifungal presented as a strength/form unknown for topical use. It treats superficial fungal skin infections such as athlete's foot, ringworm and jock itch in adults and children.

GNH USA supplies Niddafin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Terbinafine is an allylamine antifungal used to treat common superficial fungal infections of the skin. - Tinea pedis (athlete's foot): reduces itching and clears the infection on the feet. - Tinea corporis (ringworm): eliminates the characteristic ring‑shaped lesions on the body. - Tinea cruris (jock itch): relieves redness and scaling in the groin area.

Terbinafine topical may cause local skin reactions.

Common Side Effects: - Burning sensation at the application site - Itching or pruritus - Redness or erythema - Dryness or scaling of the skin - Stinging or tingling feeling - Mild irritation or discomfort

Serious or Rare Side Effects: - Allergic contact dermatitis - Severe skin rash or urticaria - Angioedema - Stevens‑Johnson syndrome (rare) - Bullous pemphigoid‑like reactions - Systemic hypersensitivity reactions

When using Niddafin, consider the following precautions. - Assess for hypersensitivity: discontinue if allergic reaction occurs. - Avoid application on broken or inflamed skin: may increase irritation. - Do not apply to mucous membranes or eyes: product is for external use only. - Limit use in children under 2 years unless directed by a healthcare professional. - Store at room temperature: keep in the original container, protect from moisture and heat.

Terbinafine topical has limited systemic interactions, but certain combinations may affect safety or efficacy.

Major Interactions (Avoid): - Concurrent use with systemic terbinafine: may increase risk of systemic toxicity. - Application over large areas combined with other topical antifungals containing azoles: may cause excessive irritation.

Moderate Interactions (Monitor Closely): - Use with topical corticosteroids: may mask signs of infection. - Co‑application with skin irritants or harsh soaps: could exacerbate local reactions. - Use on patients receiving oral retinoids: monitor for increased skin dryness.